CD4 and COVID-19: While individuals with acute or recovered COVID‐19 showed a median of 26 different spike peptide‐specific CD4+ T‐cell responses (range 10–39), vaccinated individuals responded to a median of 29 CD4+ T‐cell specificities (range 13–41).